233 related articles for article (PubMed ID: 30940767)
1. TRPV1 promotes opioid analgesia during inflammation.
Basso L; Aboushousha R; Fan CY; Iftinca M; Melo H; Flynn R; Agosti F; Hollenberg MD; Thompson R; Bourinet E; Trang T; Altier C
Sci Signal; 2019 Apr; 12(575):. PubMed ID: 30940767
[TBL] [Abstract][Full Text] [Related]
2. Development of an effective topical liposomal formulation for localized analgesia and anti-inflammatory actions in the Complete Freund's Adjuvant rodent model of acute inflammatory pain.
Iwaszkiewicz KS; Hua S
Pain Physician; 2014; 17(6):E719-35. PubMed ID: 25415787
[TBL] [Abstract][Full Text] [Related]
3. Electroacupuncture Attenuates CFA-induced Inflammatory Pain by suppressing Nav1.8 through S100B, TRPV1, Opioid, and Adenosine Pathways in Mice.
Liao HY; Hsieh CL; Huang CP; Lin YW
Sci Rep; 2017 Feb; 7():42531. PubMed ID: 28211895
[TBL] [Abstract][Full Text] [Related]
4. Mu-opioid receptor activation modulates transient receptor potential vanilloid 1 (TRPV1) currents in sensory neurons in a model of inflammatory pain.
Endres-Becker J; Heppenstall PA; Mousa SA; Labuz D; Oksche A; Schäfer M; Stein C; Zöllner C
Mol Pharmacol; 2007 Jan; 71(1):12-8. PubMed ID: 17005903
[TBL] [Abstract][Full Text] [Related]
5. The mechanism of μ-opioid receptor (MOR)-TRPV1 crosstalk in TRPV1 activation involves morphine anti-nociception, tolerance and dependence.
Bao Y; Gao Y; Yang L; Kong X; Yu J; Hou W; Hua B
Channels (Austin); 2015; 9(5):235-43. PubMed ID: 26176938
[TBL] [Abstract][Full Text] [Related]
6. K-685, a TRPV1 antagonist, blocks PKC-sensitized TRPV1 activation and improves the inflammatory pain in a rat complete Freund's adjuvant model.
Sugimoto Y; Kojima Y; Inayoshi A; Inoue K; Miura-Kusaka H; Mori K; Saku O; Ishida H; Atsumi E; Nakasato Y; Shirakura S; Toki S; Shinoda K; Suzuki N
J Pharmacol Sci; 2013; 123(3):256-66. PubMed ID: 24162023
[TBL] [Abstract][Full Text] [Related]
7. Mother root of Aconitum carmichaelii Debeaux exerts antinociceptive effect in Complet Freund's Adjuvant-induced mice: roles of dynorpin/kappa-opioid system and transient receptor potential vanilloid type-1 ion channel.
Wang C; Sun D; Liu C; Zhu C; Jing X; Chen S; Liu C; Zhi K; Xu T; Wang H; Liu J; Xu Y; Liu Z; Lin N
J Transl Med; 2015 Aug; 13():284. PubMed ID: 26320055
[TBL] [Abstract][Full Text] [Related]
8. Naloxone-induced analgesia mediated by central kappa opioid system in chronic inflammatory pain.
Lee GJ; Kim SA; Kim YJ; Oh SB
Brain Res; 2021 Jul; 1762():147445. PubMed ID: 33766518
[TBL] [Abstract][Full Text] [Related]
9. Antinociceptive and antihyperalgesic effects of tapentadol in animal models of inflammatory pain.
Schiene K; De Vry J; Tzschentke TM
J Pharmacol Exp Ther; 2011 Nov; 339(2):537-44. PubMed ID: 21816956
[TBL] [Abstract][Full Text] [Related]
10. Endogenous opioid mechanisms partially mediate P2X3/P2X2/3-related antinociception in rat models of inflammatory and chemogenic pain but not neuropathic pain.
McGaraughty S; Honore P; Wismer CT; Mikusa J; Zhu CZ; McDonald HA; Bianchi B; Faltynek CR; Jarvis MF
Br J Pharmacol; 2005 Sep; 146(2):180-8. PubMed ID: 16041397
[TBL] [Abstract][Full Text] [Related]
11. Sigma-1 receptors control immune-driven peripheral opioid analgesia during inflammation in mice.
Tejada MA; Montilla-García A; Cronin SJ; Cikes D; Sánchez-Fernández C; González-Cano R; Ruiz-Cantero MC; Penninger JM; Vela JM; Baeyens JM; Cobos EJ
Proc Natl Acad Sci U S A; 2017 Aug; 114(31):8396-8401. PubMed ID: 28716934
[TBL] [Abstract][Full Text] [Related]
12. Treatment with Sulforaphane Produces Antinociception and Improves Morphine Effects during Inflammatory Pain in Mice.
Redondo A; Chamorro PAF; Riego G; Leánez S; Pol O
J Pharmacol Exp Ther; 2017 Dec; 363(3):293-302. PubMed ID: 28947488
[TBL] [Abstract][Full Text] [Related]
13. Role of Src kinase in regulating protein kinase C mediated phosphorylation of TRPV1.
Robilotto GL; Mohapatra DP; Shepherd AJ; Mickle AD
Eur J Pain; 2022 Oct; 26(9):1967-1978. PubMed ID: 35900227
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor transcriptionally regulates μ-opioid receptor expression in rat trigeminal ganglia.
Lee KS; Zhang Y; Asgar J; Auh QS; Chung MK; Ro JY
Neuroscience; 2016 Sep; 331():52-61. PubMed ID: 27320211
[TBL] [Abstract][Full Text] [Related]
15. Loss of μ opioid receptor signaling in nociceptors, but not microglia, abrogates morphine tolerance without disrupting analgesia.
Corder G; Tawfik VL; Wang D; Sypek EI; Low SA; Dickinson JR; Sotoudeh C; Clark JD; Barres BA; Bohlen CJ; Scherrer G
Nat Med; 2017 Feb; 23(2):164-173. PubMed ID: 28092666
[TBL] [Abstract][Full Text] [Related]
16. Implication of delta opioid receptor subtype 2 but not delta opioid receptor subtype 1 in the development of morphine analgesic tolerance in a rat model of chronic inflammatory pain.
Beaudry H; Gendron L; Morón JA
Eur J Neurosci; 2015 Apr; 41(7):901--7. PubMed ID: 25639561
[TBL] [Abstract][Full Text] [Related]
17. Targeted nanoparticles that mimic immune cells in pain control inducing analgesic and anti-inflammatory actions: a potential novel treatment of acute and chronic pain condition.
Hua S; Cabot PJ
Pain Physician; 2013; 16(3):E199-216. PubMed ID: 23703419
[TBL] [Abstract][Full Text] [Related]
18. Fasting biases μ-opioid receptors toward β-arrestin2-dependent signaling in the accumbens shell.
Scheggi S; Ferrari A; Pelliccia T; Devoto P; De Montis MG; Gambarana C
Neuroscience; 2017 Jun; 352():19-29. PubMed ID: 28391016
[TBL] [Abstract][Full Text] [Related]
19. The sigma-1 receptor curtails endogenous opioid analgesia during sensitization of TRPV1 nociceptors.
Ruiz-Cantero MC; Cortés-Montero E; Jain A; Montilla-García Á; Bravo-Caparrós I; Shim J; Sánchez-Blázquez P; Woolf CJ; Baeyens JM; Cobos EJ
Br J Pharmacol; 2023 Apr; 180(8):1148-1167. PubMed ID: 36478100
[TBL] [Abstract][Full Text] [Related]
20. Involvement of CC Chemokine Receptor 1 and CCL3 in Acute and Chronic Inflammatory Pain in Mice.
Llorián-Salvador M; González-Rodríguez S; Lastra A; Fernández-García MT; Hidalgo A; Menéndez L; Baamonde A
Basic Clin Pharmacol Toxicol; 2016 Jul; 119(1):32-40. PubMed ID: 26663750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
